title: How should acute hepatic drug effects be studied epidemiologically?
authors.forename: H A
authors.initials: HA
authors.lastname: Guess
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury; D004812:Epidemiologic Methods; D006801:Humans; D008107:Liver Diseases / Q000453:epidemiology*; D012307:Risk Factors; D012525:Saskatchewan / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants